A Two-Phase, Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 for Injection Following Single or Multiple Doses in Healthy Subjects.
Latest Information Update: 05 Feb 2026
At a glance
- Drugs BSY 001 (Primary)
- Indications Poxvirus infections
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 05 Feb 2026 New trial record